ClinicalTrials.Veeva

Menu

Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

Alcon logo

Alcon

Status

Completed

Conditions

Refractive Errors

Treatments

Device: Lehfilcon A contact lenses
Device: Multi-purpose disinfection solution
Device: Comfilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT04055519
CLY935-C007

Details and patient eligibility

About

The purpose of this study is to obtain on-eye performance data to inform contact lens product development.

Full description

Subjects are expected to attend 5 scheduled visits. The expected duration of subject participation in the study is approximately 60 days, with approximately 30 days (± 2 days) per product.

Enrollment

36 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Sign Informed Consent document.
  • Successful wear of spherical weekly/monthly soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months.
  • Possess spectacles that provide a corrected visual acuity of 20/40 or better in both eyes.
  • Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • Any eye condition or disease or use of medication that contraindicates contact lens wear.
  • Eye surgery, irregular cornea, eye injury as specified in the protocol.
  • Routinely sleeps in contact lenses at least 1 night per week over the last 3 months prior to enrollment.
  • Any use of topical ocular medications, artificial tear or rewetting drops that would require instillation during contact lens wear.
  • Habitually wears Biofinity contact lenses.
  • Other protocol-specified exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

36 participants in 2 patient groups

LID017569, then Biofinity
Other group
Description:
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product will be worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses will be removed nightly for cleaning and disinfection.
Treatment:
Device: Multi-purpose disinfection solution
Device: Comfilcon A contact lenses
Device: Lehfilcon A contact lenses
Biofinity, then LID017569
Other group
Description:
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product will be worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses will be removed nightly for cleaning and disinfection.
Treatment:
Device: Multi-purpose disinfection solution
Device: Comfilcon A contact lenses
Device: Lehfilcon A contact lenses

Trial documents
2

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems